XDive

XDive

The XDive® 5 Superfast Real-Time PCR Machine is a next-generation qPCR platform designed for ultra-rapid nucleic acid amplification, co-developed with pioneers of ultrafast PCR. Capable of completing a 40-cycle qPCR in just 5 minutes with performance on par with conventional instruments, XDive supports up to 16 reactions simultaneously with quadruplex multiplexing and panel detection of 64 targets.

When integrated with Xtractor™ and Xprep™, it enables a fully automated, sample-to-answer workflow in under 15 minutes, making it ideal for clinical diagnostics, infectious disease testing, and high-throughput molecular labs.

With TÜV certifications, ISO 13485 compliance, and FDA EUA-authorized reagent kits, the XDive is positioned as one of the fastest, most reliable PCR systems available for research and clinical applications.

Please Log In to access Additional Details and documents …

Key Bullet Points

  • Co-developed with Prof. Carl Wittwer (BioFire co-founder, pioneer of ultrafast PCR).

  • Ultra-fast performance:

    • 40-cycle qPCR in ~5 minutes.

    • RT-qPCR in ~7 minutes.

  • Throughput: 1–16 reaction wells per run, 5–30 μL per reaction.

  • Multiplexing: Up to 4 targets per tube (expandable to 6); panel detection of up to 64 targets in one run.

  • Fluorescence channels: Standard FAM, HEX, ROX, Cy5 (expandable to 6 channels).

  • Sensitivity & precision: Detects as low as ~30 copies/ml; excellent uniformity and reproducibility across wells.

  • Sample-to-result workflow:

    • With Xtractor™ nucleic acid extractor + Xprep™ reagent prep module → fully automated results in <15 minutes.

  • Thermal cycling: Translational tube movement among heating baths for ultrafast ramp rates.

    • Ramp up: 82°C/s (outside tube), 285°C/s (inside).

    • Ramp down: 67°C/s (outside tube), 17.5°C/s (inside).

    • Uniformity: ±0.5°C.

  • Compact footprint: 450×342×357 mm; weight 24.5 kg.

  • Certified:

    • TÜV-certified (IEC 61010, IEC 61326-2-6:2020).

    • Manufacturing under ISO 13485.

  • Regulatory/EUA: FDA EUA for COVID-19 RT-qPCR, SalivaDirect™, and Monkeypox kits.

Patents granted: U.S., China, EU, Japan, Australia, India, Singapore.